{'fraction_non_alphanumeric': 0.025878003696857672, 'fraction_numerical': 0.0027726432532347504, 'mean_word_length': 4.918032786885246, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
[Four cases of benign hepatic-tumors associated with oral contraception].


 4 cases of hepatic adenoma in young women are presented. The 4 patients had been taking estro-progestative contraceptive agents. The adenomas were single, double or multiple; some could be treated surgically, some were not treated because of the risk involved. In the 4 cases, the tumor was benign. The relationship between hepatic adenoma and estro-progestatives, and more generally between hepatic tumors and steriods is studied. Hepatic adenomas appear to be much more frequent than had been believed. Latent forms are probably relatively frequent. It is very likely that estro-progestatives are responsible for the benign tumors, but also for some of the malignant ones. This type of lesion also carries a risk of hemorrhage. Therefore it is crucial to detect them. In their conclusion, the authors emphasize the necessity of taking into consideration some of the serious risks which come with oral contraception, some of which are hepatic tumors, thrombosis, cerebral vascular accidents and colitis.
